Streaky pigmentation in a patient with acquired immune deficiency syndrome (AIDS).
We report a case of hyperpigmentation due to bleomycin treatment in a patient with acquired immune deficiency syndrome (AIDS). Although this type of hyperpigmentation has been previously seen in patients with cancer who are receiving bleomycin, this is, to our knowledge, the first reported case of bleomycin-induced hyperpigmentation in an AIDS patient and should be added to the growing list of cutaneous eruptions seen in these patients.
Lazar
A P
AP
Department of Dermatology, Northwestern University Medical School, Chicago, Illinois.
Lazar
P
P
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications*; D000328:Adult; D001761:Bleomycin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D008297:Male; D010859:Pigmentation Disorders / Q000139:chemically induced*; D012514:Sarcoma, Kaposi / Q000188:drug therapy* / Q000209:etiology; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000209:etiology
D001761:Bleomycin